A recent trial attempted to investigate the role of locoregional anesthesia (LA) in carotid endarterectomy (CEA) compared with general anesthesia. The hypothesis regarding the advantage of LA is based on the intraprocedural neurologic evaluation and the early identification of neurologic deficit. The trial has not demonstrated the superiority of the rocoregional anesthesia versus general anesthesia and revealed equal results concerning the prevention of stroke. We analyze the reasons which explain why the hypothesis regarding the advantage of LA in CEA, in comparison to general anesthesia cannot be answered. Angiology 61(7) 624-626 ª The Author(s) 2010 Reprints and permission: sagepub.com/journalsPermissions.nav
A recent study attempted to investigate the role of locoregional anesthesia (LA) in carotid endarterectomy (CEA) in comparison to general anesthesia. 1 The hypothesis regarding the advantage of LA is based on the intraprocedural neurologic evaluation and the early identification of the patient's neurologic deficit, expressed as an altered state of consciousness, motor weakness, or seizures during a clamping test. Additional benefits include fewer cardiorespiratory complications, while preserved cerebrovascular autoregulation is under debate. 2 
The Shunt
In case of a neurologic ''drop,'' a shunt is inserted to establish arterial flow in the carotid artery and to maintain constant blood flow to the brain. A shunt may malfunction, can cause intimal damage or dissect the wall, dislodge plaque and debris, and eventually cause secondary thromboembolism. Surgeons operating under general anesthesia tend to be routine, selective, or do not use a shunt. Although the strategy of shunting remains under debate, selective shunters believe shunts are only necessary in 10% to 15% of patients. 3 Randomized trials have failed to demonstrate which strategy is best. 4 The GALA Trial and the Use of Shunting Interestingly, in the recently published GALA trial, 43% (738 of 1753) of patients undergoing general anesthesia required shunts. This shunt was routine in, surprisingly, 50% (368 of 738) of the cases observed. The main criteria used to determine the indication for a shunt in the general surgery group were hemodynamic parameters of transcranial Doppler (TCD), grade of stenosis or occlusion of the contralateral carotid artery, carotid stump pressure, and clinical considerations. In the local anesthesia group, the respective percentage of shunt use was 14% (248 of 1773). In 60% (150 of 248) of these patients, the indication for a shunt was based on neurologic deterioration during a clamping test. Forty percent (98 of 248) of the patients shunted in the group of local anesthesia did not exhibit neurological deterioration.
A stroke occurred in 4% of patients assigned to surgery under general anesthesia and in 3.7% of those assigned to surgery under local anesthesia. This difference was not proven to be significant. No information correlating with the rate of stroke in patients in which a shunt was used is reported in the GALA trial.
Locoregional Anesthesia and Use of Shunts
The recent multicenter randomized GALA trial has not demonstrated the superiority of LA versus general anesthesia and revealed equal results concerning the prevention of stroke. 1 Limitations of the trial have been discussed by various authors. 5, 6 Two interesting points related to the use of shunt should be addressed.
First, the early and accurate identification of a neurological event during carotid clamping reflects a critical level of brain ischemia, indicating the use of a shunt during endarterectomy. While this hypothesis seems obvious and self-evident, there are no published data, experimental or clinical, describing the eventual damage of brain parenchyma in various levels of critical ischemia. Loss of consciousness may indicate severe cerebral ischemia, and it is an indication of shunting, but we do not know the eventual risk for the brain when, during the carotid artery clamping test, 1 patient expresses slight motor weakness of the fingers or the arm, or a slight drop in consciousness level. No experimental studies exist to describe the level of brain ischemia and outcome, while a clinical study of CEA under LA without shunting, independently of manifested neurological symptoms, would be unethical. A percentage of patients, during carotid clamping, only express mild-to-moderate neurologic deficits. What would happen if we continued operating on the patient without a shunt? How many patients, undergoing operations with general anesthesia but without shunting and neurological deficits, would have manifested such a deficit during carotid clamping and local anesthesia? While it seems reasonable to hypothesize that this patient has an increased risk of ischemic stroke, it remains difficult to predict the outcome. Patients with gravely compromised collateral perfusion through an incomplete Willis may be the only group of patients who indisputably benefit from the use of shunts.
Traditionally, hypoperfusion and embolism are considered separate but significant causes of stroke. In the literature, clinical and experimental data suggest that in most instances, hypoperfusion due to a central stenosis causes either no symptoms or attacks of transient brain ischemia, without inducing major brain infarction. 7 Gradual hypoperfusion, due to atherosclerotic occlusive disease, gives ample time and stimulus for the development of adequate collateral blood flow. However, hypoperfusion and embolism often coexist, and their pathophysiological features are interactive. 8 Reduced perfusion limits the ability of the bloodstream to clear emboli and reduces available blood flow to regions rendered ischemic by emboli that block supply arteries. Hypoperfusion with embolism and embolism alone, due to a vulnerable unstable carotid plaque, are the most common explanations of stroke. A shunt restores a hypoperfusion state, but it does not eliminate the risk of embolism during CEA, which is a significant cause of cerebral stroke.
A Point Not Addressed by the GALA Trial
A critical point of debate is whether a preoperative detailed study can reliably predict when CEA can be safely performed, without the need for shunting. It has been suggested that the careful and detailed preoperative evaluation of patients, consisting of identifying risk factors and individualizing each patient's imaging findings, can predict when CEA can be safely performed without the need of a shunt. 9 However, this consideration is not supported by all authors. 10 In addition, predicting the need for a shunt based on adjunctive, intraoperative measures is defensible but not always accurate. 11, 12 The clamping test under local anesthesia is the safer test. In the GALA trial, 14% (248 of 1773) of the local anesthesia group patients were shunted. Only 8% (150 of 1773) of local anesthesia group patients required shunts, based on their neurological control. Accepting the randomized criteria of the study, we can assume that an equal number of 8% to 14% shunts would have been necessary in the general anesthesia group, instead of the 43% used. A potential advantage of this study, to demonstrate an additional benefit over general anesthesia in accurately predicting the need for a shunt, was lost, as the study did not only include selective shunting.
Conclusions
Carotid endarterectomy, with either general or local anesthesia, is proven to be an effective and safe technique. A clinical randomized study of CEA under LA without shunting, even if patients manifest neurological symptoms, compared with CEA under general anesthesia without shunting could provide a definite answer for the role of shunting in the prevention of stroke. As this study would be unethical, the hypothesis of the advantage of CEA under LA in the prevention of stroke cannot be ''controlled.'' Subsequently the role of shunting during CEA continues to remain debatable.
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